Physician profile
Michael P Mullin
NPI 1891136743
$1,623.81
in general payments reported to CMS, 2019-2025
10 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2022: $147 · 2023: $164 · 2024: $120 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $494.45 | 2019-2023 | Covera, Fluency Endovascular Stent Graft, Atlas |
| Argon Medical Devices, INC. | $212.50 | 2019 | |
| Penumbra, INC. | $170.72 | 2025 | Indigo System |
| Terumo Medical Corporation | $149.27 | 2019 | |
| Philips North America LLC | $120.26 | 2022 | |
| Balt USA, LLC | $120.01 | 2024 | Prestige Coil System |
| Cook Medical LLC | $116.52 | 2019 | |
| Boston Scientific Corporation | $115.92 | 2019 | |
| Medtronic Vascular, INC. | $102.16 | 2019 | |
| Ethicon US, LLC | $22.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mullin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.